Lataa...
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854680/ https://ncbi.nlm.nih.gov/pubmed/24025590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt322 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|